Skip to main content
Fig. 1 | Trials

Fig. 1

From: PREventing Delayed Graft Function by Driving Immunosuppressive InduCtion Treatment (PREDICT-DGF): study protocol for a randomized controlled trial

Fig. 1

Preventing delayed graft function by driving immunosuppressive induction treatment (PREDICT-DGF) study: description of the study. This randomized trial aims to compare anti-thymocyte globulin (ATG)-treated patients in parallel with a control group treated by basiliximab. The 1:1 randomized allocation of patients between groups is stratified on the clinical center, and on the hypothermic machine-perfusion device. The participation of each patient is scheduled for 3 months

Back to article page

Trials

ISSN: 1745-6215